Skip to search.
 TSX Down 0.85% TSX Ventures Down 0.29%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.73 Up 0.09(14.92%) 4:00PM EST
|After Hours : 0.77 Up 0.04 (4.79%) 7:57PM EST
Add to Portfolio
Prev Close:0.64
Open:0.65
Bid:0.40 x 400
Ask:N/A
1y Target Est:1.34
Beta:2.63
Next Earnings Date:N/A
Day's Range:0.65 - 0.80
52wk Range:0.48 - 1.54
Volume:5,976,565
Avg Vol (3m):625,190
Market Cap:47.82M
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AEZSUp 14.92%47.82M
CELGDown 1.53%94.85B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.49
Quarterly EPS Est (Dec-14) :-0.10
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback